Aurélie Barrail‐Tran

Randomised Pharmacokinetic Trial of Rifabutin with Lopinavir/Ritonavir-Antiretroviral Therapy in Patients with HIV-Associated Tuberculosis in Vietnam

Nguyễn Thị Ngọc Lan, Nguyen Thi Nguyet Thu, Aurélie Barrail‐Tran et al. · PLoS ONE · 2014 · 48 citations · Full text

Effect of Adherence as Measured by MEMS, Ritonavir Boosting, and CYP3A5 Genotype on Atazanavir Pharmacokinetics in Treatment-Naive HIV-Infected Patients

Radojka M. Savić, Aurélie Barrail‐Tran, Xavier Duval et al. · Clinical Pharmacology & Therapeutics · 2012 · 47 citations · Full text

Inhibition of Adipose Tissue Beiging by HIV Integrase Inhibitors, Dolutegravir and Bictegravir, Is Associated with Adipocyte Hypertrophy, Hypoxia, Elevated Fibrosis, and Insulin Resistance in Simian Adipose Tissue and Human Adipocytes

Kenza Ngono Ayissi, Jennifer Gorwood, Laura Pelletier et al. · Cells · 2022 · 42 citations · Full text

Metabolic Disorder, Pathology, Adipose Tissue Beiging +19

Emerging integrase inhibitor resistance mutations in raltegravir-treated HIV-1-infected patients with low-level viremia

Sébastien Gallien, Constance Delaugerre, Isabelle Charreau et al. · AIDS · 2011 · 41 citations · Full text

Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment

Nilesh Bhatt, Caroline Barau, Anjali Amin et al. · Antimicrobial Agents and Chemotherapy · 2014 · 41 citations · Full text